PharMerica Corporation
PMC
PMC was delisted on the 7th of December, 2017.
173 hedge funds and large institutions have $835M invested in PharMerica Corporation in 2016 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 55 increasing their positions, 58 reducing their positions, and 31 closing their positions.
18% more capital invested
Capital invested by funds: $708M → $835M (+$127M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 174 → 173 (-1)
3% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 31
5% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 58
90% less call options, than puts
Call options by funds: $185K | Put options by funds: $1.92M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$18.1M |
| 2 |
Millennium Management
New York
|
+$9.92M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$7.65M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$6.54M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$4.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$6.72M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$6.51M |
| 3 |
ACP
Arrowgrass Capital Partners
London,
United Kingdom
|
-$5.17M |
| 4 |
Morgan Stanley
New York
|
-$5.08M |
| 5 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$4.32M |
PMC Hedge Fund Activity: Q3 2016 in Review
173 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q3 2016, worth a combined $835M — up 18% from $708M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of PMC and 30 opened new positions — a net loss of 1 holder — while 58 trimmed existing stakes and 55 added.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $18.1M. The largest seller was Norges Bank, cutting an estimated $6.72M.
- 173 institutional investors held PharMerica Corporation (PMC) as of Q3 2016, down from 174 in Q2 2016.
- Funds reported $835M of PharMerica Corporation stock for Q3 2016, up 18% quarter-over-quarter.
- 30 funds opened new PharMerica Corporation positions in Q3 2016 and 31 closed out, a net change of -1 holder.
- The largest PharMerica Corporation buyer in Q3 2016 was Balyasny Asset Management, an estimated $18.1M added.
- The largest PharMerica Corporation seller in Q3 2016 was Norges Bank, an estimated $6.72M sold.
Based on aggregated 13F filings for Q3 2016.